AGCO recently announced the creation of PTx, a new brand that represents a unification of precision ag technology providers from AGCO’s tech stack, which includes Precision Planting and its ...
New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...
Preclinical data support a selective and potent effect of PTX-35 on activated CD8+ T cells ... at the Dana-Farber Cancer Institute, Harvard Medical School has suggested it may have a unique ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback